Stage IV ovarian cancer: Prognostic factors and survival beyond 5 years

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3729-3732

  Scholz, Heinz S ^a   Benedicic, Christoph ^a   Haas, Josef ^a   Tamussino, Karl ^a   Petru, Edgar ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Long term survival; Ovarian cancer; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0035570794     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer
2. A review of 28 years of treating advanced ovarian cancer
3. Long-term survival in stage III and IV ovarian cancer
4. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases
5. Stage IV ovarian cancer: Impact of surgical debulking
6. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer
7. Effect of surgical debulking on survival in stage IV ovarian cancer
8. Does agressive therapy improve survival in suboptimal stage IIIc/and IV ovarian cancer? A Canadian -American comparative study
9. Natural history of stage IV epithelial ovarian cancer
10. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma
11. Long-term results of a cisplatincontaining combination chemotherapy regimen for the treatment of advanced ovarian carcinoma
12. Platinum compounds and paclitaxel in advanced epithelial ovarian cancer